Work

Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer.

Year: 2002

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: James L Murray, Michael E Gillogly, Donna Przepiorka, Hannah Brewer, Nuhad K Ibrahim, Daniel J Booser, Gabriel N Hortobagyi, Andrzej P Kudelka, Kenneth H Grabstein, Martin A Cheever, Constantin G Ioannides

Institutions: The University of Texas MD Anderson Cancer Center, Baylor College of Medicine, GlaxoSmithKline (United Kingdom)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W1587782817

FWCI: 2.424

Cites: 28

Cited by: 137

Related to: 10